Healthcare provider profile · identity verified

Angella Samuels, DNP

Nurse Practitioner · SNELLVILLE, GA · NPI 1043406069

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	369	52
Amlodipine Besylate	Amlodipine Besylate	274	47
Trazodone Hcl	Trazodone Hcl	231	42
Levothyroxine Sodium	Levothyroxine Sodium	196	30
Memantine Hcl	Memantine Hcl	190	27
Quetiapine Fumarate	Quetiapine Fumarate	174	30
Sertraline Hcl	Sertraline Hcl	162	23
Losartan Potassium	Losartan Potassium	158	27
Lisinopril	Lisinopril	151	22
Donepezil Hcl	Donepezil Hcl	144	26
Carvedilol	Carvedilol	133	22
Clopidogrel	Clopidogrel Bisulfate	101	14
Escitalopram Oxalate	Escitalopram Oxalate	92	16
Hydralazine Hcl	Hydralazine Hcl	87	15
Tamsulosin Hcl	Tamsulosin Hcl	82	13
Gabapentin	Gabapentin	81	12
Pantoprazole Sodium	Pantoprazole Sodium	81	17
Citalopram Hbr	Citalopram Hydrobromide	80	13
Eliquis	Apixaban	78	14
Furosemide	Furosemide	78	16
Metformin Hcl	Metformin Hcl	77	18
Mirtazapine	Mirtazapine	73	15
Metoprolol Succinate	Metoprolol Succinate	72	14
Olanzapine	Olanzapine	72	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	68	suppressed
Divalproex Sodium	Divalproex Sodium	67	suppressed
Torsemide	Torsemide	61	12
Omeprazole	Omeprazole	57	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	55	11
Buspirone Hcl	Buspirone Hcl	54	12
Metoprolol Tartrate	Metoprolol Tartrate	53	13
Finasteride	Finasteride	52	suppressed
Nateglinide	Nateglinide	50	suppressed
Pravastatin Sodium	Pravastatin Sodium	49	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	48	suppressed
Potassium Chloride	Potassium Chloride	48	suppressed
Divalproex Sodium Er	Divalproex Sodium	47	suppressed
Alendronate Sodium	Alendronate Sodium	46	suppressed
Famotidine	Famotidine	44	suppressed
Metolazone	Metolazone	42	suppressed
Myrbetriq	Mirabegron	42	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	41	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	41	suppressed
Linzess	Linaclotide	40	suppressed
Spironolactone	Spironolactone	40	11
Nifedipine Er	Nifedipine	38	suppressed
Aripiprazole	Aripiprazole	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Lorazepam	Lorazepam	36	13
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Risperidone	Risperidone	31	suppressed
Simvastatin	Simvastatin	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Benztropine Mesylate	Benztropine Mesylate	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Allopurinol	Allopurinol	22	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Imipramine Hcl	Imipramine Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Valsartan	Valsartan	20	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Cephalexin	Cephalexin	14	12
Diltiazem 12hr Er	Diltiazem Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Temazepam	Temazepam	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clozapine	Clozapine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Methimazole	Methimazole	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Paliperidone Er	Paliperidone	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Primidone	Primidone	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Verapamil Er Pm	Verapamil Hcl	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Clonidine	Clonidine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error